MALAT1 and chronic myelogenous leukemia, BCR-ABL1 positive: In addition, MALAT1 silencing greatly blocked the cell cycle of chronic myeloid leukemia (CML) cells and inhibited cell proliferation by releasing the sponging effect on miR-328, which attenuated the chemotherapy resistance of CML cells to imatinib [66].